Our Members Asked:
I read that famotidine (Pepcid) may help treat COVID-19. Is this true? Might a proton pump inhibitor, like Prilosec, help?
Interest in famotidine for treating COVID-19 (caused by the coronavirus SARS-CoV-2 infection) was triggered by a preliminary report that people in China with COVID-19 who had taken famotidine for its approved use (as an "H2 blocker" to reduce stomach acidity) had better outcomes than people who were not taking it or who had been using other types of acid reducers, such as Prilosec (omeprazole — a proton pump inhibitor or PPI).
However, famotidine has not been shown to prevent SARS-Cov-2 infection and although some preliminary studies and reports suggested a possible benefit of famotidine in people with COVID-19, a large study of hospitalized COVID-19 patients given famotidine upon admission found no benefit.
PPI use may increase the risk of some microbial infections, but it does not seem to affect the risk of SARS-Cov-2 infection. Preliminary evidence has found PPI use to be associated with increased risk of COVID-19 being severe, although not with death.
Sign in for the full answer with the evidence regarding famotidine and PPIs in COVID-19 treatment and prevention, as well as potential side effects of famotidine.
Join today to unlock all member benefits including full access to all CL Answers and over 1,400 reviews.Join Now
Already a member? Sign In Here.
Join now at www.consumerlab.com/join/
Submit your comment
This feature is restricted to active members.
Join now to add comments and get all member benefits, including over 1,400 reviews.Join Now
Already a member? Sign in here.
Agree to Comment Terms
Please abide by the following:
For your privacy, only your first name (from your account) followed by a random number will appear with your comment. Your last name and email address will not be displayed.
Your comment has been submitted
We will review your comment before it is posted.